betahistine has been researched along with Hakim Syndrome in 1 studies
Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Blanco, R | 1 |
| Guerrero-Molina, MP | 1 |
| González-de la Aleja, J | 1 |
| Ruiz-Morales, J | 1 |
1 other study available for betahistine and Hakim Syndrome
| Article | Year |
|---|---|
Acute Pisa syndrome secondary to betahistine treatment in a patient with mild cognitive impairment.
Topics: Aged; Betahistine; Cognitive Dysfunction; Dystonic Disorders; Female; Humans; Hydrocephalus, Normal | 2018 |